Satou Tsukasa, Ishikawa Hitoshi, Goseki Toshiaki, Asakawa Ken
Department of Orthoptics and Visual Sciences, School of Health Sciences, International University of Health and Welfare, Tochigi, Japan.
Department of Ophthalmology, Kitasato University School of Medicine, Kanagawa, Japan.
Neuroophthalmology. 2017 Sep 25;42(3):146-149. doi: 10.1080/01658107.2017.1380050. eCollection 2018 Jun.
We evaluated the amplitude and latency scores in the RAPDx® device together with other ophthalmic examinations, before and after treatment in four patients with optic nerve disease. In all patients, the visual acuity (VA) and visual field (VF) after treatment was resolved. Both scores after treatment were lower, with reduced laterality-based differences in VA and critical flicker fusion frequency (CFF). Even after treatment, 3 patients had laterality-based differences in circumpapillary retinal nerve fiber layer thickness (cpRFNLT). Both scores for evaluation of RAPD by RAPDx® correlated with subjective examinations and were useful for evaluation of the efficacy of treatment.
我们在4例视神经疾病患者治疗前后，使用RAPDx®设备评估了振幅和潜伏期评分，并进行了其他眼科检查。所有患者治疗后的视力（VA）和视野（VF）均得到改善。治疗后的两项评分均较低，基于双眼差异的VA和临界闪烁融合频率（CFF）降低。即使在治疗后，3例患者的视乳头周围视网膜神经纤维层厚度（cpRFNLT）仍存在基于双眼差异。RAPDx®评估RAPD的两项评分均与主观检查相关，有助于评估治疗效果。
